SCHEMBL22200817

SCHEMBL22200817

CC(C)n1c(=O)c(-c2ccc(NSCCC(C)(F)F)nc2)nc2cnc(N)nc21

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTOR P42345 5/20 0.40
ERN1 O75460 3/20 0.35
RORC P51449 1/20 0.34
PIK3CA P42336 4/20 0.33
ALDH1A1 P00352 3/20 0.32
CYP1A2 P05177 3/20 0.32
HSD17B10 Q99714 3/20 0.32
MEN1 O00255 2/20 0.32
USP2 O75604 2/20 0.32
CASP1 P29466 2/20 0.32
CASP7 P55210 2/20 0.32
KMT2A Q03164 2/20 0.32
LMNA P02545 1/20 0.32
GLA P06280 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
HIF1A Q16665 1/20 0.32
CYP2D6 P10635 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22200531 0.86 ERN1 (0.42) MTORERN1RORCPIK3CAALDH1A1
SCHEMBL25035616 0.85 MTOR (0.41) MTORERN1RORCPIK3CAALDH1A1
SCHEMBL22200634 0.82 MTOR (0.41) MTORRORCALDH1A1CYP1A2HSD17B10
SCHEMBL22200787 0.82 MTOR (0.40) MTORERN1RORCPIK3CAALDH1A1
SCHEMBL25035555 0.81 MTOR (0.42) MTORERN1RORCPIK3CAALDH1A1
SCHEMBL22200792 0.80 MTOR (0.35) MTORRORCPIK3CA
SCHEMBL22200355 0.80 ERN1 (0.41) MTORERN1RORCPIK3CAALDH1A1
SCHEMBL22200435 0.78 PIK3CA (0.44) MTORPIK3CA
SCHEMBL22200719 0.78 ERN1 (0.42) MTORERN1RORCPIK3CAALDH1A1
SCHEMBL22200802 0.77 MTOR (0.41) MTORPIK3CAALDH1A1CYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142612-A1 PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. GENENTECH, INC. (US) 2020-07-09 WO disclosed